This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Olivier Ludemann-Hombourger, PhD
Director, Global Innovation and Technology at PolyPeptide Group


Olivier Ludemann-Hombourger is the Global Director Innovation & Technology at PolyPeptide. He received his PhD in 2001 from the “Institut National PolyTechnique de Lorraine” in France, in collaboration with Novasep Process, for which he was leading the R&D activity over 10 years. He worked during three years for Lonza in Braine l’Alleud (Belgium) as head of Operations, before joining PolyPeptide as General Manager of the French entity for 7 years, until taking his current global position in 2019.

Agenda Sessions

  • Replacing DMF by Greener Solvents for Peptide Synthesis: Challenges and Opportunities